Rhodes Pharmaceuticals, L.P.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Coventry RI United States (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2010
NCT01239030
First Marketed Drug
2007
theophylline (synophylate)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Rhodes Phamaceuticals, L.P. | RHODES PHARMS